Combination Therapy in Bladder Cancer:: Special Issue

Clinical Medicine Research

Special Issue

Combination Therapy in Bladder Cancer

Submission deadline: Aug. 09, 2024

Status: Open for Submission

Special Issue of Clinical Medicine Research

Bladder cancer is a common and challenging tumor, and the effectiveness and side effects of traditional treatment methods have always been a difficult problem faced by patients and doctors. However, recent studies have shown that combination therapy of immunotherapy and chemotherapy may change the treatment landscape of bladder cancer, providing better treatment outcomes and quality of life for patients.

This special issue aims to gather the latest research findings and clinical practice experiences from the academic community, both domestically and internationally, in the field of combination therapy of immunotherapy and chemotherapy in bladder cancer. Within this topic, we warmly welcome submissions in basic science research, clinical research, bioinformatics research, and review articles, with an emphasis on novel technologies and theories. We hope this topic can provide new biomarkers for cancer immunotherapy resistance, elucidate potential mechanistic pathways, and provide compelling evidence for overcoming this process in clinical applications. We encourage submissions covering the following research topics:

(1) The fundamental principles and mechanisms of immunotherapy and chemotherapy

(2) Strategies for the combination therapy of immunotherapy and chemotherapy in bladder cancer treatment

(3) Evaluation of the therapeutic efficacy and clinical practice results of immunotherapy and chemotherapy

(4) Applications and prospects of personalized treatment in combination therapy of immunotherapy and chemotherapy

(5) The potential of combination therapy of immunotherapy and chemotherapy in bladder cancer prevention and recovery

(6) Applications of combination therapy of immunotherapy and chemotherapy in specific subtypes and stages of bladder cancer

(7) Management of side effects and safety evaluation in combination therapy of immunotherapy and chemotherapy

Keywords:

Bladder Cancer
Immunotherapy
Chemotherapy
Combination
Therapy
Personalized Treatment
Efficacy Evaluation
Future Directions

Lead Guest Editor

Weigang Ren

Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China

Guest Editor

Xin Jin

Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China
Wei Xiong

Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China
Mou Peng

Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China
Liang Zhu

Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China
Yunliang Gao

Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China
Lu Yi

Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China

Manuscript Submission

Submitting your research to Science Publishing Group is a simple and efficient process. Here are three submission options available:

Manuscript writing and formatting guidelines, please refer to Submission Guidelines.

Option 1: Quick Submission

Our Quick Submission tool provides a fast and uncomplicated way for you to submit your manuscripts.

Selected Special Issue:*

Special Issue Title	Article Processing Charge
Combination Therapy in Bladder Cancer	1070 USD

Article Title: *

Upload Manuscript:*

Upload

1. Allow only .doc, .docx and .tex format.
2. Files should not exceed 20MB.

Article Type: *

First Name:*

Last Name:*

Email Address:*

A follow-up email will be sent to the given email address within 3 working days.

Verification Code: *

Renew

Option 2: Online Submission

Submit your manuscript via our online submission system.

	For unregistered users, please register at https://sso.sciencepg.com/register
	For registered users, please log in at https://sso.sciencepg.com/login

Once you're logged in, click on "Submit to Special Issue" under the "Submission" section. Follow the system prompts to successfully complete the submission.

Option 3: Email Submission

You can submit your manuscript directly via email to submission@sciencepg.com.

Please type "Combination Therapy in Bladder Cancer Manuscript Submission" as the subject of your email.